The HVTN is supported through a cooperative agreement with the National Institute of Allergy and...
Transcript of The HVTN is supported through a cooperative agreement with the National Institute of Allergy and...
![Page 1: The HVTN is supported through a cooperative agreement with the National Institute of Allergy and Infectious Diseases HVTN 505 Lessons learned in year 1.](https://reader036.fdocuments.in/reader036/viewer/2022081602/55163caa550346b2068b516c/html5/thumbnails/1.jpg)
The HVTN is supported through a cooperative agreementwith the National Institute of Allergy and Infectious Diseases
HVTN 505Lessons learned in year 1
Niles Eaton, MPHManager, Community Education Unit
HVTN Core Operations Center
Draft – 12 Nov 2010
![Page 2: The HVTN is supported through a cooperative agreement with the National Institute of Allergy and Infectious Diseases HVTN 505 Lessons learned in year 1.](https://reader036.fdocuments.in/reader036/viewer/2022081602/55163caa550346b2068b516c/html5/thumbnails/2.jpg)
![Page 3: The HVTN is supported through a cooperative agreement with the National Institute of Allergy and Infectious Diseases HVTN 505 Lessons learned in year 1.](https://reader036.fdocuments.in/reader036/viewer/2022081602/55163caa550346b2068b516c/html5/thumbnails/3.jpg)
HIV Vaccine trials in US MSM at high risk
0
200
400
600
800
1000
1200
1400
1600
CumulativeExpected
CumulativeEnrolled
![Page 4: The HVTN is supported through a cooperative agreement with the National Institute of Allergy and Infectious Diseases HVTN 505 Lessons learned in year 1.](https://reader036.fdocuments.in/reader036/viewer/2022081602/55163caa550346b2068b516c/html5/thumbnails/4.jpg)
Where are we now?
5/30
/200
9
6/25
/200
9
7/21
/200
9
8/16
/200
9
9/11
/200
9
10/7
/200
9
11/2
/200
9
11/2
8/20
09
12/2
4/20
09
1/19
/201
0
2/14
/201
0
3/12
/201
0
4/7/
2010
5/3/
2010
5/29
/201
0
6/24
/201
0
7/20
/201
0
8/15
/201
0
9/10
/201
0
10/6
/201
0
11/1
/201
0
11/2
7/20
10
12/2
3/20
10
1/18
/201
1
2/13
/201
1
3/11
/201
1
4/6/
2011
5/2/
2011
5/28
/201
1
6/23
/201
1
7/19
/201
1
8/14
/201
1
9/9/
2011
0
200
400
600
800
1000
1200
1400
1600
CumulativeExpected
CumulativeEnrolled
![Page 5: The HVTN is supported through a cooperative agreement with the National Institute of Allergy and Infectious Diseases HVTN 505 Lessons learned in year 1.](https://reader036.fdocuments.in/reader036/viewer/2022081602/55163caa550346b2068b516c/html5/thumbnails/5.jpg)
5/30
/200
9
6/15
/200
9
7/1/
2009
7/17
/200
9
8/2/
2009
8/18
/200
9
9/3/
2009
9/19
/200
9
10/5
/200
9
10/2
1/20
09
11/6
/200
9
11/2
2/20
09
12/8
/200
9
12/2
4/20
09
1/9/
2010
1/25
/201
0
2/10
/201
0
2/26
/201
0
3/14
/201
0
3/30
/201
0
4/15
/201
0
5/1/
2010
5/17
/201
0
6/2/
2010
6/18
/201
0
7/4/
2010
7/20
/201
0
8/5/
2010
8/21
/201
0
9/6/
2010
9/22
/201
0
10/8
/201
0
10/2
4/20
10
11/9
/201
0
11/2
5/20
10
12/1
1/20
10
12/2
7/20
10
1/12
/201
10
200
400
600
800
1000
1200
CumulativeExpected
CumulativeEnrolled
HVTN 505 enrollment, an iterative process
Version 2.0 approved: risk criteria simplification & specific language on
transgender
Initial Core-generated materials available
Amendment: upper age limit elevated to 50
Rapid needs assessment of all sites
Site expansion process
![Page 6: The HVTN is supported through a cooperative agreement with the National Institute of Allergy and Infectious Diseases HVTN 505 Lessons learned in year 1.](https://reader036.fdocuments.in/reader036/viewer/2022081602/55163caa550346b2068b516c/html5/thumbnails/6.jpg)
Strategies Initiated by HVTN Core: May 2010
Working Only So-So Not Working N/A In Process (TBD)
Hope Takes Action web contacts 3 6 1
Facebook Ads 1 2 3 3 1
Banner ads on hook-up websites 1 2 7Twitter 5 4 1
Media stories initiated by HVTN Core 3 6 1
Transit advertising (bus, train, etc.) 2 3 1 4
Bus bench/shelter ads 1 2 3 4
Phone kiosk ads 1 9
Print ads in local paper(s) 4 2 3 1
Hope Takes Action Posters 2 2 5 1
Hope Takes Action Palm cards 2 5 2 1
Hope Takes Action Post Cards 1 5 2 2
Hope Takes Action small poster w/ tear-off pads 2 2 5 1
Hope Takes Action drink coasters 2 1 7Hope Takes Action give-away items: Condoms 3 4 3
Hope Takes Action give-away items: Bags 4 3 3
Hope Takes Action give-away items: Lip Balm 5 3 2
Hope Takes Action give-away items: Yo-Yos 7 1 2
Hope Takes Action give-away items: Gum 8 1 1Hope Takes Action give-away items: Hand Sanitizer 6 2 2
Other give-aways (rubber duckies, etc.) 1 1 8
Cling ads for bathroom posting 1 7 2
Hope Takes Action table tents 1 3 4 2
T-shirts for recruiters 3 3 2 2
Not Working: - Banner ads on hook-up sites- Twitter- Media stories generated by HVTN Core-Hope Takes Action:
- Action Posters - Small posters with tear offs
- Coasters- Cling ads
Working:-Hope Takes Action give-aways
Lip BalmYo-yosGumHand Sanitizer
![Page 7: The HVTN is supported through a cooperative agreement with the National Institute of Allergy and Infectious Diseases HVTN 505 Lessons learned in year 1.](https://reader036.fdocuments.in/reader036/viewer/2022081602/55163caa550346b2068b516c/html5/thumbnails/7.jpg)
Survey of HVTN 505 sites, May 2010Referral Source:
Screened EnrolledBar/Street/Other Outreach 312 66 (38%)Internet 398 40 (23%)Core placed ads 153 10 (6%)Site placed ads/flyers 354 23 (13%)Other (referrals, rollovers, unk) 240 30 (18%)To be classified 28 2 (<1%)
1485 171
*missing: Birmingham, Los Angeles, VRC
![Page 8: The HVTN is supported through a cooperative agreement with the National Institute of Allergy and Infectious Diseases HVTN 505 Lessons learned in year 1.](https://reader036.fdocuments.in/reader036/viewer/2022081602/55163caa550346b2068b516c/html5/thumbnails/8.jpg)
Survey of HVTN 505 sites, Sep 2010Referral Source:
Screened EnrolledBar/Street/Other Outreach 576 145 (39%)Pride activities 49 6 (<1%)
Internet 334 80 (22%)Core placed ads 144 23 (6%)Site placed ads/flyers 245 46 (12%)Other (referrals, rollovers, unk) 257 67 (18%)To be classified 1 3 (<1%)
Total 1606 370
![Page 9: The HVTN is supported through a cooperative agreement with the National Institute of Allergy and Infectious Diseases HVTN 505 Lessons learned in year 1.](https://reader036.fdocuments.in/reader036/viewer/2022081602/55163caa550346b2068b516c/html5/thumbnails/9.jpg)
CEU & Legacy Project staffSite Visits
Main objective: assess recruitment & screening process for any obvious gaps
Collect & disseminate best practices Provide recommendations Report to Community Affairs & Site
Assistance Working Group (CASA) for additional review & feedback
![Page 10: The HVTN is supported through a cooperative agreement with the National Institute of Allergy and Infectious Diseases HVTN 505 Lessons learned in year 1.](https://reader036.fdocuments.in/reader036/viewer/2022081602/55163caa550346b2068b516c/html5/thumbnails/10.jpg)
HVTN 505 branding: evolution & customizing
![Page 11: The HVTN is supported through a cooperative agreement with the National Institute of Allergy and Infectious Diseases HVTN 505 Lessons learned in year 1.](https://reader036.fdocuments.in/reader036/viewer/2022081602/55163caa550346b2068b516c/html5/thumbnails/11.jpg)
Jul-09 Aug-09
Sep-09
Oct-09
Nov-09
Dec-09
Jan-10 Feb-10
Mar-10
Apr-10
May-10
Jun-10 Jul-10 Aug-10
Sep-10
Oct-10
Nov-10
(half)
0
10000
20000
30000
40000
50000
60000
Visitors to HopeTakesAction.org
Web & social media: generating contacts
Jul-09 Aug-09
Sep-09
Oct-09
Nov-09
Dec-09
Jan-10 Feb-10
Mar-10
Apr-10
May-10
Jun-10 Jul-10 Aug-10
Sep-10
Oct-10
Nov-10
(half)
0
100
200
300
400
500
Contact Cards completed
New campaigns launched
Changed Facebook ad targeting
![Page 12: The HVTN is supported through a cooperative agreement with the National Institute of Allergy and Infectious Diseases HVTN 505 Lessons learned in year 1.](https://reader036.fdocuments.in/reader036/viewer/2022081602/55163caa550346b2068b516c/html5/thumbnails/12.jpg)
Site developed brands & materials
![Page 13: The HVTN is supported through a cooperative agreement with the National Institute of Allergy and Infectious Diseases HVTN 505 Lessons learned in year 1.](https://reader036.fdocuments.in/reader036/viewer/2022081602/55163caa550346b2068b516c/html5/thumbnails/13.jpg)
Summary of lessons learned
It can take time for the community to respond to a study starting up
Make materials available prior to study start, or plan on “lead-in” period
Evaluate, tweak & refresh strategies, campaigns and processes
R E L E N T L E S S L Y
![Page 14: The HVTN is supported through a cooperative agreement with the National Institute of Allergy and Infectious Diseases HVTN 505 Lessons learned in year 1.](https://reader036.fdocuments.in/reader036/viewer/2022081602/55163caa550346b2068b516c/html5/thumbnails/14.jpg)
Summary of lessons learned
Recognize the balance between local site initiatives and national campaigns, and accommodate
Sites can have other priorities Recognize and acknowledge good work
when you see it
![Page 15: The HVTN is supported through a cooperative agreement with the National Institute of Allergy and Infectious Diseases HVTN 505 Lessons learned in year 1.](https://reader036.fdocuments.in/reader036/viewer/2022081602/55163caa550346b2068b516c/html5/thumbnails/15.jpg)
Acknowledgements
The site staff making first contact with potential participants
The trial participants, without whom this work would not be possible